Clinical Trial Update: Trametinib With or Without Whole Brain Radiation Therapy in Treating Patients With Brain Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating trametinib with or without whole brain radiation therapy for brain metastases. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Trametinib (trametinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Malignant Neoplasm in the Brain | Phase 1 | Status: ACTIVE_NOT_RECRUITING